LRP6 and Alzheimer disease: The LRP6-mediated Wnt signaling pathway is, in fact, compromised in AD brains, and its deficiency in an AD mouse model exacerbates amyloid pathology, synapse loss and Aβ toxicity, synergistically accelerating AD progression [104].